aluates Reports

$ 0.0

Automative

Global Compounding Chemotherapy Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-1B13180

Global Compounding Chemotherapy Market Research Report 2023

BUY CHAPTERS

Global Compounding Chemotherapy Market Research Report 2025

Code: QYRE-Auto-1B13180

Report

June 2025

Pages:111

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Braun Melsungen AG

Pfizer Inc

Baxter

Grifols SA

The Metrix Company

Equashield

Millers Pharmacy

Comecer S.p.A.

Omnicell

Icon Group

ARXIUM

Sterline

Loccioni

Added Pharma

Dedalus Group

Compounding Chemotherapy Market Size

The global market for Compounding Chemotherapy was valued at US$ 503 million in the year 2024 and is projected to reach a revised size of US$ 777 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Compounding Chemotherapy Market

The compounding chemotherapy market is showing significant growth. Compounding of drugs makes them patient-specific which is the biggest advantage. Compounding chemotherapy can minimize the risk of underdose or overdose of drugs for a patient. Therefore, owing to its numerous advantages.

Cancer, bone marrow diseases, immune problems, and other conditions that require chemotherapy treatment are becoming more common in the recent years.

This report aims to provide a comprehensive presentation of the global market for Compounding Chemotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compounding Chemotherapy.

The Compounding Chemotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Compounding Chemotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Compounding Chemotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Compounding Chemotherapy Market Report

Report Metric	Details
Report Name	Compounding Chemotherapy Market
Accounted market size in year	US$ 503 million
Forecasted market size in 2031	US$ 777 million
CAGR	6.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Gravimetric Automated Compounding Device (Weight-Based) Volumetric Automated Compounding Device (Volume-Based)
Segment by Application	Breast Cancer Blood Cancer Prostate Cancer Gastrointestinal Cancer Respiratory/Lung Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Braun Melsungen AG, Pfizer Inc., Baxter, Grifols SA, The Metrix Company, Added Pharma, Equashield, Millers Pharmacy, Comecer S.P.A., Omnicell, Icon group, Dedalus Group, Arxium, Sterline S.R.L., Loccioni
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Compounding Chemotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Compounding Chemotherapy Market growing?

Ans: The Compounding Chemotherapy Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Compounding Chemotherapy Market size in 2031?

Ans: The Compounding Chemotherapy Market size in 2031 will be US$ 777 million.

Who are the main players in the Compounding Chemotherapy Market report?

Ans: The main players in the Compounding Chemotherapy Market are Braun Melsungen AG, Pfizer Inc., Baxter, Grifols SA, The Metrix Company, Added Pharma, Equashield, Millers Pharmacy, Comecer S.P.A., Omnicell, Icon group, Dedalus Group, Arxium, Sterline S.R.L., Loccioni

What are the Application segmentation covered in the Compounding Chemotherapy Market report?

Ans: The Applications covered in the Compounding Chemotherapy Market report are Breast Cancer, Blood Cancer, Prostate Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Others

What are the Type segmentation covered in the Compounding Chemotherapy Market report?

Ans: The Types covered in the Compounding Chemotherapy Market report are Gravimetric Automated Compounding Device (Weight-Based), Volumetric Automated Compounding Device (Volume-Based)

Recommended Reports

Cancer Drug Markets

Cancer Treatment Segments

Precision & Personalized Oncology

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Compounding Chemotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Gravimetric Automated Compounding Device (Weight-Based)

1.2.3 Volumetric Automated Compounding Device (Volume-Based)

1.2.4 Gravimetric Automated Compounding Device (Weight-Based)

1.2.5 Volumetric Automated Compounding Device (Volume-Based)

1.3 Market by Application

1.3.1 Global Compounding Chemotherapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Breast Cancer

1.3.3 Blood Cancer

1.3.4 Prostate Cancer

1.3.5 Gastrointestinal Cancer

1.3.6 Respiratory/Lung Cancer

1.3.7 Others

1.3.8 Breast Cancer

1.3.9 Blood Cancer

1.3.10 Prostate Cancer

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Compounding Chemotherapy Market Perspective (2020-2031)

2.2 Global Compounding Chemotherapy Growth Trends by Region

2.2.1 Global Compounding Chemotherapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Compounding Chemotherapy Historic Market Size by Region (2020-2025)

2.2.3 Compounding Chemotherapy Forecasted Market Size by Region (2026-2031)

2.3 Compounding Chemotherapy Market Dynamics

2.3.1 Compounding Chemotherapy Industry Trends

2.3.2 Compounding Chemotherapy Market Drivers

2.3.3 Compounding Chemotherapy Market Challenges

2.3.4 Compounding Chemotherapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Compounding Chemotherapy Players by Revenue

3.1.1 Global Top Compounding Chemotherapy Players by Revenue (2020-2025)

3.1.2 Global Compounding Chemotherapy Revenue Market Share by Players (2020-2025)

3.2 Global Compounding Chemotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Compounding Chemotherapy Revenue

3.4 Global Compounding Chemotherapy Market Concentration Ratio

3.4.1 Global Compounding Chemotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Compounding Chemotherapy Revenue in 2024

3.5 Global Key Players of Compounding Chemotherapy Head office and Area Served

3.6 Global Key Players of Compounding Chemotherapy, Product and Application

3.7 Global Key Players of Compounding Chemotherapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Compounding Chemotherapy Breakdown Data by Type

4.1 Global Compounding Chemotherapy Historic Market Size by Type (2020-2025)

4.2 Global Compounding Chemotherapy Forecasted Market Size by Type (2026-2031)

5 Compounding Chemotherapy Breakdown Data by Application

5.1 Global Compounding Chemotherapy Historic Market Size by Application (2020-2025)

5.2 Global Compounding Chemotherapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Compounding Chemotherapy Market Size (2020-2031)

6.2 North America Compounding Chemotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Compounding Chemotherapy Market Size by Country (2020-2025)

6.4 North America Compounding Chemotherapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Compounding Chemotherapy Market Size (2020-2031)

7.2 Europe Compounding Chemotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Compounding Chemotherapy Market Size by Country (2020-2025)

7.4 Europe Compounding Chemotherapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Compounding Chemotherapy Market Size (2020-2031)

8.2 Asia-Pacific Compounding Chemotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Compounding Chemotherapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Compounding Chemotherapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Compounding Chemotherapy Market Size (2020-2031)

9.2 Latin America Compounding Chemotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Compounding Chemotherapy Market Size by Country (2020-2025)

9.4 Latin America Compounding Chemotherapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Compounding Chemotherapy Market Size (2020-2031)

10.2 Middle East & Africa Compounding Chemotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Compounding Chemotherapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Compounding Chemotherapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Braun Melsungen AG

11.1.1 Braun Melsungen AG Company Details

11.1.2 Braun Melsungen AG Business Overview

11.1.3 Braun Melsungen AG Compounding Chemotherapy Introduction

11.1.4 Braun Melsungen AG Revenue in Compounding Chemotherapy Business (2020-2025)

11.1.5 Braun Melsungen AG Recent Development

11.2 Pfizer Inc.

11.2.1 Pfizer Inc. Company Details

11.2.2 Pfizer Inc. Business Overview

11.2.3 Pfizer Inc. Compounding Chemotherapy Introduction

11.2.4 Pfizer Inc. Revenue in Compounding Chemotherapy Business (2020-2025)

11.2.5 Pfizer Inc. Recent Development

11.3 Baxter

11.3.1 Baxter Company Details

11.3.2 Baxter Business Overview

11.3.3 Baxter Compounding Chemotherapy Introduction

11.3.4 Baxter Revenue in Compounding Chemotherapy Business (2020-2025)

11.3.5 Baxter Recent Development

11.4 Grifols SA

11.4.1 Grifols SA Company Details

11.4.2 Grifols SA Business Overview

11.4.3 Grifols SA Compounding Chemotherapy Introduction

11.4.4 Grifols SA Revenue in Compounding Chemotherapy Business (2020-2025)

11.4.5 Grifols SA Recent Development

11.5 The Metrix Company

11.5.1 The Metrix Company Company Details

11.5.2 The Metrix Company Business Overview

11.5.3 The Metrix Company Compounding Chemotherapy Introduction

11.5.4 The Metrix Company Revenue in Compounding Chemotherapy Business (2020-2025)

11.5.5 The Metrix Company Recent Development

11.6 Added Pharma

11.6.1 Added Pharma Company Details

11.6.2 Added Pharma Business Overview

11.6.3 Added Pharma Compounding Chemotherapy Introduction

11.6.4 Added Pharma Revenue in Compounding Chemotherapy Business (2020-2025)

11.6.5 Added Pharma Recent Development

11.7 Equashield

11.7.1 Equashield Company Details

11.7.2 Equashield Business Overview

11.7.3 Equashield Compounding Chemotherapy Introduction

11.7.4 Equashield Revenue in Compounding Chemotherapy Business (2020-2025)

11.7.5 Equashield Recent Development

11.8 Millers Pharmacy

11.8.1 Millers Pharmacy Company Details

11.8.2 Millers Pharmacy Business Overview

11.8.3 Millers Pharmacy Compounding Chemotherapy Introduction

11.8.4 Millers Pharmacy Revenue in Compounding Chemotherapy Business (2020-2025)

11.8.5 Millers Pharmacy Recent Development

11.9 Comecer S.P.A.

11.9.1 Comecer S.P.A. Company Details

11.9.2 Comecer S.P.A. Business Overview

11.9.3 Comecer S.P.A. Compounding Chemotherapy Introduction

11.9.4 Comecer S.P.A. Revenue in Compounding Chemotherapy Business (2020-2025)

11.9.5 Comecer S.P.A. Recent Development

11.10 Omnicell

11.10.1 Omnicell Company Details

11.10.2 Omnicell Business Overview

11.10.3 Omnicell Compounding Chemotherapy Introduction

11.10.4 Omnicell Revenue in Compounding Chemotherapy Business (2020-2025)

11.10.5 Omnicell Recent Development

11.11 Icon group

11.11.1 Icon group Company Details

11.11.2 Icon group Business Overview

11.11.3 Icon group Compounding Chemotherapy Introduction

11.11.4 Icon group Revenue in Compounding Chemotherapy Business (2020-2025)

11.11.5 Icon group Recent Development

11.12 Dedalus Group

11.12.1 Dedalus Group Company Details

11.12.2 Dedalus Group Business Overview

11.12.3 Dedalus Group Compounding Chemotherapy Introduction

11.12.4 Dedalus Group Revenue in Compounding Chemotherapy Business (2020-2025)

11.12.5 Dedalus Group Recent Development

11.13 Arxium

11.13.1 Arxium Company Details

11.13.2 Arxium Business Overview

11.13.3 Arxium Compounding Chemotherapy Introduction

11.13.4 Arxium Revenue in Compounding Chemotherapy Business (2020-2025)

11.13.5 Arxium Recent Development

11.14 Sterline S.R.L.

11.14.1 Sterline S.R.L. Company Details

11.14.2 Sterline S.R.L. Business Overview

11.14.3 Sterline S.R.L. Compounding Chemotherapy Introduction

11.14.4 Sterline S.R.L. Revenue in Compounding Chemotherapy Business (2020-2025)

11.14.5 Sterline S.R.L. Recent Development

11.15 Loccioni

11.15.1 Loccioni Company Details

11.15.2 Loccioni Business Overview

11.15.3 Loccioni Compounding Chemotherapy Introduction

11.15.4 Loccioni Revenue in Compounding Chemotherapy Business (2020-2025)

11.15.5 Loccioni Recent Development

11.16 Braun Melsungen AG

11.16.1 Braun Melsungen AG Company Details

11.16.2 Braun Melsungen AG Business Overview

11.16.3 Braun Melsungen AG Compounding Chemotherapy Introduction

11.16.4 Braun Melsungen AG Revenue in Compounding Chemotherapy Business (2020-2025)

11.16.5 Braun Melsungen AG Recent Development

11.17 Pfizer Inc.

11.17.1 Pfizer Inc. Company Details

11.17.2 Pfizer Inc. Business Overview

11.17.3 Pfizer Inc. Compounding Chemotherapy Introduction

11.17.4 Pfizer Inc. Revenue in Compounding Chemotherapy Business (2020-2025)

11.17.5 Pfizer Inc. Recent Development

11.18 Baxter

11.18.1 Baxter Company Details

11.18.2 Baxter Business Overview

11.18.3 Baxter Compounding Chemotherapy Introduction

11.18.4 Baxter Revenue in Compounding Chemotherapy Business (2020-2025)

11.18.5 Baxter Recent Development

11.19 Grifols SA

11.19.1 Grifols SA Company Details

11.19.2 Grifols SA Business Overview

11.19.3 Grifols SA Compounding Chemotherapy Introduction

11.19.4 Grifols SA Revenue in Compounding Chemotherapy Business (2020-2025)

11.19.5 Grifols SA Recent Development

11.20 The Metrix Company

11.20.1 The Metrix Company Company Details

11.20.2 The Metrix Company Business Overview

11.20.3 The Metrix Company Compounding Chemotherapy Introduction

11.20.4 The Metrix Company Revenue in Compounding Chemotherapy Business (2020-2025)

11.20.5 The Metrix Company Recent Development

11.21 Added Pharma

11.21.1 Added Pharma Company Details

11.21.2 Added Pharma Business Overview

11.21.3 Added Pharma Compounding Chemotherapy Introduction

11.21.4 Added Pharma Revenue in Compounding Chemotherapy Business (2020-2025)

11.21.5 Added Pharma Recent Development

11.22 Equashield

11.22.1 Equashield Company Details

11.22.2 Equashield Business Overview

11.22.3 Equashield Compounding Chemotherapy Introduction

11.22.4 Equashield Revenue in Compounding Chemotherapy Business (2020-2025)

11.22.5 Equashield Recent Development

11.23 Millers Pharmacy

11.23.1 Millers Pharmacy Company Details

11.23.2 Millers Pharmacy Business Overview

11.23.3 Millers Pharmacy Compounding Chemotherapy Introduction

11.23.4 Millers Pharmacy Revenue in Compounding Chemotherapy Business (2020-2025)

11.23.5 Millers Pharmacy Recent Development

11.24 Comecer S.P.A.

11.24.1 Comecer S.P.A. Company Details

11.24.2 Comecer S.P.A. Business Overview

11.24.3 Comecer S.P.A. Compounding Chemotherapy Introduction

11.24.4 Comecer S.P.A. Revenue in Compounding Chemotherapy Business (2020-2025)

11.24.5 Comecer S.P.A. Recent Development

11.25 Omnicell

11.25.1 Omnicell Company Details

11.25.2 Omnicell Business Overview

11.25.3 Omnicell Compounding Chemotherapy Introduction

11.25.4 Omnicell Revenue in Compounding Chemotherapy Business (2020-2025)

11.25.5 Omnicell Recent Development

11.26 Icon group

11.26.1 Icon group Company Details

11.26.2 Icon group Business Overview

11.26.3 Icon group Compounding Chemotherapy Introduction

11.26.4 Icon group Revenue in Compounding Chemotherapy Business (2020-2025)

11.26.5 Icon group Recent Development

11.27 Dedalus Group

11.27.1 Dedalus Group Company Details

11.27.2 Dedalus Group Business Overview

11.27.3 Dedalus Group Compounding Chemotherapy Introduction

11.27.4 Dedalus Group Revenue in Compounding Chemotherapy Business (2020-2025)

11.27.5 Dedalus Group Recent Development

11.28 Arxium

11.28.1 Arxium Company Details

11.28.2 Arxium Business Overview

11.28.3 Arxium Compounding Chemotherapy Introduction

11.28.4 Arxium Revenue in Compounding Chemotherapy Business (2020-2025)

11.28.5 Arxium Recent Development

11.29 Sterline S.R.L.

11.29.1 Sterline S.R.L. Company Details

11.29.2 Sterline S.R.L. Business Overview

11.29.3 Sterline S.R.L. Compounding Chemotherapy Introduction

11.29.4 Sterline S.R.L. Revenue in Compounding Chemotherapy Business (2020-2025)

11.29.5 Sterline S.R.L. Recent Development

11.30 Loccioni

11.30.1 Loccioni Company Details

11.30.2 Loccioni Business Overview

11.30.3 Loccioni Compounding Chemotherapy Introduction

11.30.4 Loccioni Revenue in Compounding Chemotherapy Business (2020-2025)

11.30.5 Loccioni Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Braun Melsungen AG

Pfizer Inc

Baxter

Grifols SA

The Metrix Company

Equashield

Millers Pharmacy

Comecer S.p.A.

Omnicell

Icon Group

ARXIUM

Sterline

Loccioni

Added Pharma

Dedalus Group

List of Tables

Table 1. Global Compounding Chemotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Gravimetric Automated Compounding Device (Weight-Based)

Table 3. Key Players of Volumetric Automated Compounding Device (Volume-Based)

Table 4. Key Players of Gravimetric Automated Compounding Device (Weight-Based)

Table 5. Key Players of Volumetric Automated Compounding Device (Volume-Based)

Table 6. Global Compounding Chemotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Compounding Chemotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Compounding Chemotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Compounding Chemotherapy Market Share by Region (2020-2025)

Table 10. Global Compounding Chemotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Compounding Chemotherapy Market Share by Region (2026-2031)

Table 12. Compounding Chemotherapy Market Trends

Table 13. Compounding Chemotherapy Market Drivers

Table 14. Compounding Chemotherapy Market Challenges

Table 15. Compounding Chemotherapy Market Restraints

Table 16. Global Compounding Chemotherapy Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Compounding Chemotherapy Market Share by Players (2020-2025)

Table 18. Global Top Compounding Chemotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compounding Chemotherapy as of 2024)

Table 19. Ranking of Global Top Compounding Chemotherapy Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Compounding Chemotherapy Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Compounding Chemotherapy, Headquarters and Area Served

Table 22. Global Key Players of Compounding Chemotherapy, Product and Application

Table 23. Global Key Players of Compounding Chemotherapy, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Compounding Chemotherapy Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Compounding Chemotherapy Revenue Market Share by Type (2020-2025)

Table 27. Global Compounding Chemotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Compounding Chemotherapy Revenue Market Share by Type (2026-2031)

Table 29. Global Compounding Chemotherapy Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Compounding Chemotherapy Revenue Market Share by Application (2020-2025)

Table 31. Global Compounding Chemotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Compounding Chemotherapy Revenue Market Share by Application (2026-2031)

Table 33. North America Compounding Chemotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Compounding Chemotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Compounding Chemotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Compounding Chemotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Compounding Chemotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Compounding Chemotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Compounding Chemotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Compounding Chemotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Compounding Chemotherapy Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Compounding Chemotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Compounding Chemotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Compounding Chemotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Compounding Chemotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Compounding Chemotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Compounding Chemotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 48. Braun Melsungen AG Company Details

Table 49. Braun Melsungen AG Business Overview

Table 50. Braun Melsungen AG Compounding Chemotherapy Product

Table 51. Braun Melsungen AG Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 52. Braun Melsungen AG Recent Development

Table 53. Pfizer Inc. Company Details

Table 54. Pfizer Inc. Business Overview

Table 55. Pfizer Inc. Compounding Chemotherapy Product

Table 56. Pfizer Inc. Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 57. Pfizer Inc. Recent Development

Table 58. Baxter Company Details

Table 59. Baxter Business Overview

Table 60. Baxter Compounding Chemotherapy Product

Table 61. Baxter Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 62. Baxter Recent Development

Table 63. Grifols SA Company Details

Table 64. Grifols SA Business Overview

Table 65. Grifols SA Compounding Chemotherapy Product

Table 66. Grifols SA Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 67. Grifols SA Recent Development

Table 68. The Metrix Company Company Details

Table 69. The Metrix Company Business Overview

Table 70. The Metrix Company Compounding Chemotherapy Product

Table 71. The Metrix Company Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 72. The Metrix Company Recent Development

Table 73. Added Pharma Company Details

Table 74. Added Pharma Business Overview

Table 75. Added Pharma Compounding Chemotherapy Product

Table 76. Added Pharma Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 77. Added Pharma Recent Development

Table 78. Equashield Company Details

Table 79. Equashield Business Overview

Table 80. Equashield Compounding Chemotherapy Product

Table 81. Equashield Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 82. Equashield Recent Development

Table 83. Millers Pharmacy Company Details

Table 84. Millers Pharmacy Business Overview

Table 85. Millers Pharmacy Compounding Chemotherapy Product

Table 86. Millers Pharmacy Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 87. Millers Pharmacy Recent Development

Table 88. Comecer S.P.A. Company Details

Table 89. Comecer S.P.A. Business Overview

Table 90. Comecer S.P.A. Compounding Chemotherapy Product

Table 91. Comecer S.P.A. Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 92. Comecer S.P.A. Recent Development

Table 93. Omnicell Company Details

Table 94. Omnicell Business Overview

Table 95. Omnicell Compounding Chemotherapy Product

Table 96. Omnicell Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 97. Omnicell Recent Development

Table 98. Icon group Company Details

Table 99. Icon group Business Overview

Table 100. Icon group Compounding Chemotherapy Product

Table 101. Icon group Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 102. Icon group Recent Development

Table 103. Dedalus Group Company Details

Table 104. Dedalus Group Business Overview

Table 105. Dedalus Group Compounding Chemotherapy Product

Table 106. Dedalus Group Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 107. Dedalus Group Recent Development

Table 108. Arxium Company Details

Table 109. Arxium Business Overview

Table 110. Arxium Compounding Chemotherapy Product

Table 111. Arxium Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 112. Arxium Recent Development

Table 113. Sterline S.R.L. Company Details

Table 114. Sterline S.R.L. Business Overview

Table 115. Sterline S.R.L. Compounding Chemotherapy Product

Table 116. Sterline S.R.L. Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 117. Sterline S.R.L. Recent Development

Table 118. Loccioni Company Details

Table 119. Loccioni Business Overview

Table 120. Loccioni Compounding Chemotherapy Product

Table 121. Loccioni Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 122. Loccioni Recent Development

Table 123. Braun Melsungen AG Company Details

Table 124. Braun Melsungen AG Business Overview

Table 125. Braun Melsungen AG Compounding Chemotherapy Product

Table 126. Braun Melsungen AG Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 127. Braun Melsungen AG Recent Development

Table 128. Pfizer Inc. Company Details

Table 129. Pfizer Inc. Business Overview

Table 130. Pfizer Inc. Compounding Chemotherapy Product

Table 131. Pfizer Inc. Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 132. Pfizer Inc. Recent Development

Table 133. Baxter Company Details

Table 134. Baxter Business Overview

Table 135. Baxter Compounding Chemotherapy Product

Table 136. Baxter Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 137. Baxter Recent Development

Table 138. Grifols SA Company Details

Table 139. Grifols SA Business Overview

Table 140. Grifols SA Compounding Chemotherapy Product

Table 141. Grifols SA Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 142. Grifols SA Recent Development

Table 143. The Metrix Company Company Details

Table 144. The Metrix Company Business Overview

Table 145. The Metrix Company Compounding Chemotherapy Product

Table 146. The Metrix Company Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 147. The Metrix Company Recent Development

Table 148. Added Pharma Company Details

Table 149. Added Pharma Business Overview

Table 150. Added Pharma Compounding Chemotherapy Product

Table 151. Added Pharma Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 152. Added Pharma Recent Development

Table 153. Equashield Company Details

Table 154. Equashield Business Overview

Table 155. Equashield Compounding Chemotherapy Product

Table 156. Equashield Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 157. Equashield Recent Development

Table 158. Millers Pharmacy Company Details

Table 159. Millers Pharmacy Business Overview

Table 160. Millers Pharmacy Compounding Chemotherapy Product

Table 161. Millers Pharmacy Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 162. Millers Pharmacy Recent Development

Table 163. Comecer S.P.A. Company Details

Table 164. Comecer S.P.A. Business Overview

Table 165. Comecer S.P.A. Compounding Chemotherapy Product

Table 166. Comecer S.P.A. Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 167. Comecer S.P.A. Recent Development

Table 168. Omnicell Company Details

Table 169. Omnicell Business Overview

Table 170. Omnicell Compounding Chemotherapy Product

Table 171. Omnicell Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 172. Omnicell Recent Development

Table 173. Icon group Company Details

Table 174. Icon group Business Overview

Table 175. Icon group Compounding Chemotherapy Product

Table 176. Icon group Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 177. Icon group Recent Development

Table 178. Dedalus Group Company Details

Table 179. Dedalus Group Business Overview

Table 180. Dedalus Group Compounding Chemotherapy Product

Table 181. Dedalus Group Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 182. Dedalus Group Recent Development

Table 183. Arxium Company Details

Table 184. Arxium Business Overview

Table 185. Arxium Compounding Chemotherapy Product

Table 186. Arxium Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 187. Arxium Recent Development

Table 188. Sterline S.R.L. Company Details

Table 189. Sterline S.R.L. Business Overview

Table 190. Sterline S.R.L. Compounding Chemotherapy Product

Table 191. Sterline S.R.L. Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 192. Sterline S.R.L. Recent Development

Table 193. Loccioni Company Details

Table 194. Loccioni Business Overview

Table 195. Loccioni Compounding Chemotherapy Product

Table 196. Loccioni Revenue in Compounding Chemotherapy Business (2020-2025) & (US$ Million)

Table 197. Loccioni Recent Development

Table 198. Research Programs/Design for This Report

Table 199. Key Data Information from Secondary Sources

Table 200. Key Data Information from Primary Sources

Table 201. Authors List of This Report

List of Figures

Figure 1. Compounding Chemotherapy Picture

Figure 2. Global Compounding Chemotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Compounding Chemotherapy Market Share by Type: 2024 VS 2031

Figure 4. Gravimetric Automated Compounding Device (Weight-Based) Features

Figure 5. Volumetric Automated Compounding Device (Volume-Based) Features

Figure 6. Gravimetric Automated Compounding Device (Weight-Based) Features

Figure 7. Volumetric Automated Compounding Device (Volume-Based) Features

Figure 8. Global Compounding Chemotherapy Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Compounding Chemotherapy Market Share by Application: 2024 VS 2031

Figure 10. Breast Cancer Case Studies

Figure 11. Blood Cancer Case Studies

Figure 12. Prostate Cancer Case Studies

Figure 13. Gastrointestinal Cancer Case Studies

Figure 14. Respiratory/Lung Cancer Case Studies

Figure 15. Others Case Studies

Figure 16. Breast Cancer Case Studies

Figure 17. Blood Cancer Case Studies

Figure 18. Prostate Cancer Case Studies

Figure 19. Compounding Chemotherapy Report Years Considered

Figure 20. Global Compounding Chemotherapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 21. Global Compounding Chemotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 22. Global Compounding Chemotherapy Market Share by Region: 2024 VS 2031

Figure 23. Global Compounding Chemotherapy Market Share by Players in 2024

Figure 24. Global Top Compounding Chemotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compounding Chemotherapy as of 2024)

Figure 25. The Top 10 and 5 Players Market Share by Compounding Chemotherapy Revenue in 2024

Figure 26. North America Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. North America Compounding Chemotherapy Market Share by Country (2020-2031)

Figure 28. United States Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Canada Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe Compounding Chemotherapy Market Share by Country (2020-2031)

Figure 32. Germany Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. France Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. U.K. Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Italy Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Russia Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Nordic Countries Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Compounding Chemotherapy Market Share by Region (2020-2031)

Figure 40. China Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Japan Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. India Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Australia Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America Compounding Chemotherapy Market Share by Country (2020-2031)

Figure 48. Mexico Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Brazil Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa Compounding Chemotherapy Market Share by Country (2020-2031)

Figure 52. Turkey Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. UAE Compounding Chemotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Braun Melsungen AG Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 56. Pfizer Inc. Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 57. Baxter Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 58. Grifols SA Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 59. The Metrix Company Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 60. Added Pharma Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 61. Equashield Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 62. Millers Pharmacy Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 63. Comecer S.P.A. Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 64. Omnicell Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 65. Icon group Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 66. Dedalus Group Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 67. Arxium Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 68. Sterline S.R.L. Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 69. Loccioni Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 70. Braun Melsungen AG Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 71. Pfizer Inc. Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 72. Baxter Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 73. Grifols SA Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 74. The Metrix Company Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 75. Added Pharma Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 76. Equashield Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 77. Millers Pharmacy Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 78. Comecer S.P.A. Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 79. Omnicell Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 80. Icon group Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 81. Dedalus Group Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 82. Arxium Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 83. Sterline S.R.L. Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 84. Loccioni Revenue Growth Rate in Compounding Chemotherapy Business (2020-2025)

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030

Global Compounding Pharmacy Service Market Research Report 2025

Nephroblastoma Chemotherapy Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemotherapy Pump Market Research Report 2024

Automated Drug Compounding Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Custom Compounded Therapy Market Research Report 2025

Global Compounding Systems Market Research Report 2024

Global Chemotherapy Infusion Set Market Insights Forecast to 2030

Global Cancer Infusion Therapy Market Insights Forecast to 2030

Chemotherapy At Home Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chemotherapy Cold Hat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemotherapy Induced Anemia Drug Market Research Report 2024

Chemotherapy induced Cardiotoxicity Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chemotherapy Intravenous Infusion Pump Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

IV Compounding Robots Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Personalizing Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Imatinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Containment Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemo Pumps Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions